Article Information
History
- April 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kazuo Imaia,b,c,*,
- Sakiko Tabataa,
- Mayu Ikedaa,
- Sakiko Noguchid,
- Yutaro Kitagawad,
- Masaru Matsuokad,
- Kazuyasu Miyoshia,
- Norihito Tarumotob,c,
- Jun Sakaib,c,
- Toshimitsu Itoa,
- Shigefumi Maesakib,c,
- Kaku Tamuraa and
- Takuya Maedac,d
- aCOVID-19 Task Force, Self-Defense Forces Central Hospital, Tokyo, Japan
- bDepartment of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan
- cCenter for Clinical Infectious Diseases and Research, Saitama Medical University, Saitama, Japan
- dDepartment of Clinical Laboratory, Saitama Medical University, Saitama, Japan
- ↵*Corresponding author
Kazuo Imai, M.D., Self-Defense Forces Central Hospital, 24-2-1 Ikejiri, Setagaya-ku, Tokyo, 154-0001, Japan, Department of Infectious Disease and Infection Control, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan, E-mail: k_imai{at}saitama-med.ac.jp, Tel: +81-3-3411-0151 or +81-3-49-276-1111
Posted April 27, 2020.
Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19
